Public-registry site landscape for NCT07742644, a Measles study sponsored by GlaxoSmithKline. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07742644 (registry record) |
| Sponsor | GlaxoSmithKline |
| Condition(s) | Measles; Mumps; Rubella; Varicella (Chickenpox) |
| Phase | PHASE3 |
| Listed sites | 62 |
| Site countries | United States, Argentina, Finland, Italy, Puerto Rico, Taiwan |
Eichor generates a preliminary site-risk snapshot for NCT07742644 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →